A Phase 1b Dose-Escalation Study Of Trc105 (Anti-Endoglin Antibody) In Combination With Axitinib In Patients With Metastatic Renal Cell Carcinoma (Mrcc)
ANNALS OF ONCOLOGY(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF ONCOLOGY(2014)